Cortisone associated diverticular perforation

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Patients on glucocorticosteroid therapy are at increased risk of gastrointestinal perforation. The associated morbidity and mortality of perforations in this group is increased, compared with normal groups. This difference is due to the delay between onset of clinical symptoms and treatment. In the presence of steroids, gastrointestinal perforation is more difficult to diagnose clinically because signs and symptoms of perforation are masked by the anti-inflammatory effect of the steroids.

Author supplied keywords

Cite

CITATION STYLE

APA

Goethals, L., Nieboer, K., De Smet, K., De Geeter, F., Tabrizi, N. H., Van Eetvelde, E., & de Mey, J. (2011). Cortisone associated diverticular perforation. JBR-BTR, 94(6), 348–349. https://doi.org/10.5334/jbr-btr.705

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free